Literature DB >> 11896267

Resources required for global tuberculosis control.

Katherine Floyd1, Leopold Blanc, Mario Raviglione, Jong-Wook Lee.   

Abstract

We estimate that to achieve the World Health Organization's tuberculosis control targets, the 22 high-burden countries (HBCs) that collectively account for approximately 80% of the world's tuberculosis cases require about $1 billion per year during the period 2001 to 2005. A further $0.2 billion per year is needed for low and lower-middle income countries outside the 22 HBCs. There is a resource gap of up to around $300 million per year. Substantial progress in tuberculosis control could be achieved with increased investment that is large in the context of existing spending, but small in the wider context of global health expenditure.

Entities:  

Mesh:

Year:  2002        PMID: 11896267     DOI: 10.1126/science.1069771

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  10 in total

1.  Evolution of drug resistance in different sublineages of Mycobacterium tuberculosis Beijing genotype.

Authors:  Igor Mokrousov; Wei Wei Jiao; Gui Zhi Sun; Jia Wen Liu; Violeta Valcheva; Mo Li; Olga Narvskaya; A Dong Shen
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

2.  The long-term health and economic benefits of DOTS implementation in Ecuador.

Authors:  Olivia Oxlade; Judyth Vaca; Elizabeth Romero; Kevin Schwartzman; Brian Graham; Lucero Hernandez; Terry Tannenbaum; Dick Menzies
Journal:  Can J Public Health       Date:  2006 Jan-Feb

3.  Financing tuberculosis control: the role of a global financial monitoring system.

Authors:  Katherine Floyd; Andrea Pantoja; Christopher Dye
Journal:  Bull World Health Organ       Date:  2007-05       Impact factor: 9.408

4.  Financial resources required for tuberculosis control to achieve global targets set for 2015.

Authors:  Katherine Floyd; Andrea Pantoja
Journal:  Bull World Health Organ       Date:  2008-07       Impact factor: 9.408

5.  Defining approaches to settlement mapping for public health management in Kenya using medium spatial resolution satellite imagery.

Authors:  Andrew J Tatem; Abdisalan M Noor; Simon I Hay
Journal:  Remote Sens Environ       Date:  2004-10-30       Impact factor: 10.164

6.  Unexpectedly high proportion of ancestral Manu genotype Mycobacterium tuberculosis strains cultured from tuberculosis patients in Egypt.

Authors:  Zeinab H Helal; Mohamed Seif El-Din Ashour; Somaia A Eissa; Ghanem Abd-Elatef; Thierry Zozio; Sankhiros Babapoor; Nalin Rastogi; Mazhar I Khan
Journal:  J Clin Microbiol       Date:  2009-06-24       Impact factor: 5.948

7.  Identification of mannich base as a novel inhibitor of Mycobacterium tuberculosis isocitrate by high-throughput screening.

Authors:  Lei Ji; Quanxin Long; Dacheng Yang; Jianping Xie
Journal:  Int J Biol Sci       Date:  2011-04-07       Impact factor: 6.580

8.  Impact of DOTS expansion on tuberculosis related outcomes and costs in Haiti.

Authors:  Vary Jacquet; Willy Morose; Kevin Schwartzman; Olivia Oxlade; Graham Barr; Franque Grimard; Dick Menzies
Journal:  BMC Public Health       Date:  2006-08-15       Impact factor: 3.295

9.  Resource utilization pattern and cost of tuberculosis treatment from the provider and patient perspectives in the state of Penang, Malaysia.

Authors:  Muhammad Atif; Syed Azhar Syed Sulaiman; Asrul Akmal Shafie; Muhammad Asif; Zaheer-Ud-Din Babar
Journal:  BMC Health Serv Res       Date:  2014-08-19       Impact factor: 2.655

10.  Targeted screening and treatment for latent tuberculosis infection using QuantiFERON-TB Gold is cost-effective in Mexico.

Authors:  J L Burgos; J G Kahn; S A Strathdee; A Valencia-Mendoza; S Bautista-Arredondo; R Laniado-Laborin; R Castañeda; R Deiss; R S Garfein
Journal:  Int J Tuberc Lung Dis       Date:  2009-08       Impact factor: 3.427

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.